Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 13 - 24 items out of 359 results
ILCN article
Therapeutic Vaccine Development in Lung Cancer: Update and Recent Advances
ILCN article
Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for Developing Countries
ILCN article
Ablation Techniques for Lung Nodules: Percutaneous or Transbronchial Approach?
ILCN article
Savolitinib Approved in China for MET-Positive NSCLC
ILCN article
Durvalumab Plus Chemotherapy Approved in China as First-Line Management of Extensive-stage SCLC
ILCN article
Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer
ILCN article
Addition of Nivolumab to Neoadjuvant Chemotherapy in NSCLC: Results of CheckMate-816
ILCN article
Second-Line, Biomarker-Driven Therapies for Squamous NSCLC: Report on Lung-MAP SWOG S1400
ILCN article
China’s Domestic PD-1/PD-L1 Inhibitors Demanding Global Attention
ILCN article
First Comprehensive Genomic Profiling Assay Approved for Use with Brigatinib, ALK-positive NSCLC
ILCN article
Selpercatinib Approved in Canada for Metastatic NSCLC with RET Fusions
ILCN article
Sotorasib Wins Approval for Unmet Need in KRAS G12C-Driven NSCLC
Pagination
First
First page
‹
Previous page
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page